We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+13.85%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$1.14B
AUM Growth
+$97.6M
Cap. Flow
-$16.4M
Cap. Flow %
-1.44%
Top 10 Hldgs %
20.55%
Holding
1,047
New
117
Increased
379
Reduced
323
Closed
176

Top Buys

Rank Stock Value
1
PTA icon
Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund
PTA
+$7.21M
2
TLMD
SOC Telemed, Inc. Class A Common Stock
TLMD
+$4.93M
3
SDHY
PGIM Short Duration High Yield Opportunities Fund
SDHY
+$4.14M
4
ACM icon
Aecom
ACM
+$2.7M
5
MSFT icon
Microsoft
MSFT
+$2.09M

Top Sells

Rank Stock Value
1
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$5.76M
2
FTCS icon
First Trust Capital Strength ETF
FTCS
+$4M
3
FTC icon
First Trust Large Cap Growth AlphaDEX Fund
FTC
+$3.82M
4
FV icon
First Trust Dorsey Wright Focus 5 ETF
FV
+$3.74M
5
FVD icon
First Trust Value Line Dividend Fund
FVD
+$3.61M

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Consumer Discretionary 9.64%
3 Healthcare 9.06%
4 Financials 8.14%
5 Communication Services 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GMDA
1001
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
– –
-17,715
Closed -$74K
GERM
1002
DELISTED
Amplify Treatments, Testing and Advancements ETF
GERM
– –
-13,924
Closed -$385K
ARAV
1003
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-22,100
Closed -$104K
AEY
1004
DELISTED
ADDvantage Technologies Group
AEY
– –
-5,863
Closed -$113K
ICPT
1005
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-6,611
Closed -$274K
ZYNE
1006
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-11,900
Closed -$39K
PRTK
1007
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-45,369
Closed -$245K
HARP
1008
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-1,382
Closed -$235K
ISEE
1009
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-11,000
Closed -$62K
NYMX
1010
DELISTED
Nymox Pharmaceutical Corp
NYMX
– –
-19,100
Closed -$47K
INDT
1011
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
– –
-4,148
Closed -$222K
UNAM
1012
DELISTED
Unico American Corp
UNAM
– –
-20,132
Closed -$104K
ACOR
1013
DELISTED
Acorda Therapeutics
ACOR
– –
-126
Closed -$8K
APTX
1014
DELISTED
Aptinyx Inc. Common Stock
APTX
– –
-16,200
Closed -$55K
IMV
1015
DELISTED
IMV Inc. Common Shares
IMV
– –
-1,160
Closed -$52K
NVCN
1016
DELISTED
Neovasc Inc.
NVCN
– –
-1,234
Closed -$66K
PHAS
1017
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-13,865
Closed -$49K
AMPE
1018
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
– –
-220
Closed -$63K
CHNG
1019
DELISTED
Change Healthcare Inc. Common Stock
CHNG
– –
-14,380
Closed -$209K
ALNA
1020
DELISTED
Allena Pharmaceuticals
ALNA
– –
-24,150
Closed -$36K
ATHX
1021
DELISTED
Athersys, Inc. Common Stock
ATHX
– –
-888
Closed -$43K
EPZM
1022
DELISTED
Epizyme, Inc
EPZM
– –
-26,450
Closed -$316K
MBII
1023
DELISTED
Marrone Bio Innovations, Inc.
MBII
– –
-37,129
Closed -$45K
CALA
1024
DELISTED
Calithera Biosciences, Inc
CALA
– –
-1,025
Closed -$71K
MCA
1025
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
– –
-11,523
Closed -$165K
38 39 40
41
42

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q4 2020 Portfolio in Review

As of Q4 2020, Wedbush Securities held 1,047 positions worth $1.14B, up 9.4% from $1.04B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Wedbush Securities's Q4 2020 filing shows 117 new, 379 increased, 323 reduced and 176 closed positions. Its largest new stake was Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund: 284,367 shares worth $7.39M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $5.76M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Wedbush Securities's largest Q4 2020 buy was Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund: 284,367 shares worth $7.39M.
  • Wedbush Securities added most to Microsoft in Q4 2020, an estimated $2.09M increase.
  • Wedbush Securities's biggest Q4 2020 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $5.76M.
  • Wedbush Securities fully exited First Trust Large Cap Growth AlphaDEX Fund in Q4 2020, selling an estimated $3.82M.
  • Wedbush Securities's ten largest holdings make up 21% of its $1.14B portfolio in Q4 2020.
  • Wedbush Securities opened 117 new positions and closed 176 in Q4 2020.
  • Wedbush Securities's portfolio value rose 9.4% quarter-over-quarter to $1.14B.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.